Publications by authors named "Melissa Mathias"

Claim this Profile
C
Cemiplimab in Japanese patients with advanced non-small cell lung cancer.
Yuki Sato, Yoko Tani, Hidenobu Ishii, Seigo Katakura, Masahide Oki, Melissa Mathias

Jpn J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2 clinical trial.
Domenica Lorusso, Ana Oaknin, Giuliano S Borges, Fernanda Damian, Nelleke Ottevanger, Melissa Mathias

Gynecol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial.
Ana Oaknin, Bradley J Monk, Andreia Cristina de Melo, Hee Seung Kim, Yong Man Kim, Melissa Mathias

Eur J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer.
Kosei Hasegawa, Shunji Takahashi, Kimio Ushijima, Masao Okadome, Kan Yonemori, Melissa Mathias

Cancer Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
Neil D Gross, David M Miller, Nikhil I Khushalani, Vasu Divi, Emily S Ruiz, Melissa Mathias

Lancet Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer.
Ana Oaknin, Bradley J Monk, Ignace Vergote, Andreia Cristina de Melo, Yong-Man Kim, Melissa Mathias

Eur J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
Neil D Gross, David M Miller, Nikhil I Khushalani, Vasu Divi, Emily S Ruiz, Melissa Mathias

N Engl J Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival with Cemiplimab in Recurrent Cervical Cancer.
Krishnansu S Tewari, Bradley J Monk, Ignace Vergote, Austin Miller, Andreia C de Melo, Melissa Mathias

N Engl J Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony-Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Hani Babiker, Irene Brana, Daruka Mahadevan, Taofeek Owonikoko, Emiliano Calvo, Melissa Mathias

Oncologist· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer.
Danny Rischin, Marta Gil-Martin, Antonio González-Martin, Irene Braña, June Y Hou, Melissa Mathias

Gynecol Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing.
Danny Rischin, Michael R Migden, Annette M Lim, Chrysalyne D Schmults, Nikhil I Khushalani, Melissa Mathias

J Immunother Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local Anesthesia With General Anesthesia for Pediatric Bone Marrow Procedures.
Sara Zarnegar-Lumley, Katharine R Lange, Melissa D Mathias, Miho Nakajima-Hatano, Katharine M Offer

Pediatrics· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
Michael R Migden, Danny Rischin, Chrysalyne D Schmults, Alexander Guminski, Axel Hauschild, Melissa Mathias

N Engl J Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.
Aaron Y Chang, Tao Dao, Ron S Gejman, Casey A Jarvis, Andrew Scott, Melissa D Mathias

J Clin Invest· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.
Aaron Y Chang, Tao Dao, Ron S Gejman, Casey A Jarvis, Andrew Scott, Melissa D Mathias

J Clin Invest· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-center experience with undifferentiated embryonal sarcoma of the liver.
Melissa D Mathias, Srikanth R Ambati, Alexander J Chou, Emily K Slotkin, Leonard H Wexler

Pediatr Blood Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and challenges for TCR mimic antibodies in cancer therapy.
Aaron Y Chang, Ron S Gejman, Elliott J Brea, Claire Y Oh, Melissa D Mathias

Expert Opin Biol Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteosarcoma With Apparent Ewing Sarcoma Gene Rearrangement.
Melissa D Mathias, Alexander J Chou, Paul Meyers, Neerav Shukla, Meera Hameed

J Pediatr Hematol Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of opioid administration as a quality indicator for pain crises in sickle cell disease.
Melissa D Mathias, Timothy L McCavit

Pediatrics· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice.
Paul W Denton, John F Krisko, Daniel A Powell, Melissa Mathias, Youn Tae Kwak

PLoS One· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors.
J Andrew Duty, Peter Szodoray, Nai-Ying Zheng, Kristi A Koelsch, Qingzhao Zhang, Melissa Mathias

J Exp Med· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mature B cells class switched to IgD are autoreactive in healthy individuals.
Kristi Koelsch, Nai-Ying Zheng, Qingzhao Zhang, Andrew Duty, Christina Helms, Melissa D Mathias

J Clin Invest· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Igkappa allelic inclusion is a consequence of receptor editing.
Rafael Casellas, Qingzhao Zhang, Nai-Ying Zheng, Melissa D Mathias, Kenneth Smith

J Exp Med· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis